GHRP-6 (Cardiac) (GHRP6C)

Beyond GH release, GHRP-6 has demonstrated independent cardioprotective effects in ischemia research.

Key Data

Research Status

Preclinical

Half-Life

15-30 minutes

Administration

Subcutaneous injection

Typical Dosage

100-300 mcg

Mechanism of Action

CD36 receptor activation in cardiac tissue, independent of GH release.

Reported Benefits

• Cardioprotection
• Ischemia protection
• Cardiac function
• Anti-inflammatory

All information is presented for Research Use Only (RUO). Not medical advice.